Association of Open-Angle Glaucoma with Non-Alzheimer's Dementia and Cognitive Impairment.
Summary
Open-angle glaucoma patients may have increased odds of SD, MCI, and other neurodegenerative diseases.
Abstract
PURPOSE
To compare the odds of central neurodegenerative diseases in patients with open-angle glaucoma (OAG) with the odds in patients without glaucoma (control patients).
DESIGN
Cross-sectional study.
PARTICIPANTS
Patients 18 years of age or older who visited Duke University Health System between January 1, 2000, and July 31, 2015.
METHODS
An electronic query of patient records at Duke University Health System was performed to identify patients with and without diagnoses of OAG, amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), vascular dementia (VD), senile dementia (SD), mild cognitive impairment (MCI), and other neurodegenerative diseases. Univariate logistic regression analyses were performed to calculate unadjusted odds ratios (OR). Age group, race, and gender were included as covariates in multiple logistic regression analyses to calculate adjusted ORs.
MAIN OUTCOME MEASURES
Odds ratios comparing the odds of each neurodegenerative disease in OAG patients with the odds in control patients.
RESULTS
A total of 1 511 602 patients were included in this study: 24 892 OAG patients and 1 484 790 control patients. Mean age was 58.9 ± 14.0 years for OAG patients and 44.9 ± 14.1 years for control patients. After adjusting for age, race, and gender, the OR comparing the odds of each neurodegenerative disease in OAG patients with the odds in control patients were as follows: for
AD
adjusted OR, 0.84; 95% confidence interval (CI), 0.77-0.93; for
ALS
adjusted OR, 0.28; 95% CI, 0.14-0.49); for
PD
adjusted OR, 1.00; 95% CI, 0.89-1.13; for
VD
adjusted OR, 1.11; 95% CI, 0.99-1.25; for
SD
adjusted OR, 1.30; 95% CI, 1.19-1.41; for
MCI
adjusted OR, 2.00; 95% CI, 1.79-2.22; and for other neurodegenerative disease: adjusted OR, 1.79; 95% CI, 1.51-2.10.
CONCLUSIONS
Open-angle glaucoma patients may have increased odds of SD, MCI, and other neurodegenerative diseases. Further work is necessary to identify potential causal relationships. A negative correlation exists between OAG and ALS diagnosis that is likely related to limited life expectancy and physical limitations in ALS patients. A weak negative correlation exists between OAG and AD diagnosis. No correlation exists between OAG and PD or VD.
More by Obinna Umunakwe
View full profile →Top Research in Diagnosis & Screening
Browse all →Efficacy of a Deep Learning System for Detecting Glaucomatous Optic Neuropathy Based on Color Fundus Photographs.
Dry eye disease and oxidative stress.
Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS).
Discussion
Comments and discussion will appear here in a future update.